Regulation of osteoclastogenesis by transcriptional repressor Blimp1 via epigenetic regulation
Project/Area Number |
23592231
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Orthopaedic surgery
|
Research Institution | Keio University |
Principal Investigator |
|
Project Period (FY) |
2011 – 2013
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2012: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Keywords | 破骨細胞 / 骨粗鬆症 / 骨代謝 / 転写因子 |
Research Abstract |
Osteoclasts are unique bone resorbing cells, and thus are therapeutic targets to treat bone diseases such as osteoporosis. We found that B lymphocyte induced maturation protein 1 (Blimp1), a transcriptional repressor, was required for osteoclastogenesis. Although Blimp1-null mutant mice are embryonic lethal, Blimp1 conditional knockout at an adult stage by a Cre/loxP system did not promote lethal adverse effects in mice, while resulted in significant inhibition of osteoclast formation with increased bone mass. Thus, Blimp1 was considered as a therapeutic target to treat skeletal diseases such as osteoporosis (J Biol Chem 2012).
|
Report
(4 results)
Research Products
(16 results)
-
[Journal Article] HIF1α is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis.2013
Author(s)
Miyauchi Y, Sato Y, Kobayashi T, Yoshida S, Mori T, Kanagawa H, Katsuyama E, Fujie A, Hao W, Miyamoto K, Tando T, Morioka H, Matsumoto M, Chambon P, Johnson RS, Kato S, Toyama Y, Miyamoto T.
-
Journal Title
Proc Natl Acad Sci U S A.
Volume: 110
Issue: 41
Pages: 16568-16573
DOI
Related Report
Peer Reviewed
-
[Journal Article] An essential role for STAT6-STAT1 protein signaling in promoting macrophage cell-cell fusion2012
Author(s)
Miyamoto H, Katsuyama E, Miyauchi Y, Hoshi H, Miyamoto K, Sato Y, Kobayashi T, Iwasaki R, Yoshida S, Mori T, Kanagawa H, Fujie A, Hao W, Morioka H, Matsumoto M, Toyama Y, Miyamoto T
-
Journal Title
J Biol Chem
Volume: vol. 287
Issue: 39
Pages: 32479-84
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
[Journal Article] Neovascular niche for human myeloma cells in immunodeficient mouse bone.2012
Author(s)
Iriuchishima H, Takubo K, Miyakawa Y, Nakamura-Ishizu A, Miyauchi Y, Fujita N, Miyamoto K, Miyamoto T, Ikeda E, Kizaki M, Nojima Y, Suda T.
-
Journal Title
Related Report
Peer Reviewed
-
-
[Journal Article] The IRE1α-XBP1 pathway is essential for osteoblast differentiation through promoting transcription of Osterix.2011
Author(s)
Tohmonda T, Miyauchi Y, Ghosh R, Yoda M, Uchikawa S, Takito J, Morioka H, Nakamura M, Iwawaki T, Chiba K, Toyama Y, Urano F, Horiuchi K.
-
Journal Title
EMBO Rep.
Volume: 12
Pages: 451-457
Related Report
Peer Reviewed
-
-
[Journal Article] Matrix metalloproteinase 13 in the ligamentum flavum from lumbar spinal canal stenosis patients with and without diabetes mellitus.2011
Author(s)
Cui G, Watanabe K, Miyauchi Y, Hosogane N, Tsuji T, Ishii K, Nakamura M, Toyama Y, Chiba K, Miyamoto T, Matsumoto M.
-
Journal Title
J Orthop Sci.
Volume: 16
Pages: 785-790
Related Report
Peer Reviewed
-
[Journal Article] Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization.2011
Author(s)
Miyamoto K, Yoshida S, Kawasumi M, Hashimoto K, Kimura T, Sato Y, Kobayashi T, Miyauchi Y, Morioka H, Chiba K, Kobayashi T, Yasuda H, Penninger JM, Toyama Y, Suda T, Miyamoto T.
-
Journal Title
J Exp Med.
Volume: 208
Pages: 2175-2181
Related Report
Peer Reviewed
-
-